Literature DB >> 16633006

The long-term effects of gastric bypass on vitamin D metabolism.

Jason M Johnson1, James W Maher, Eric J DeMaria, Robert W Downs, Luke G Wolfe, John M Kellum.   

Abstract

OBJECTIVE: Alterations of the endocrine system in patients following Roux-en-Y gastric bypass (GBP) are poorly described and have prompted us to perform a longitudinal study of the effects of GBP on serum calcium, 25-hydroxy-vitamin-D (vitamin D), and parathyroid hormone (PTH).
METHODS: Prospectively collected data were compiled to determine how GBP affects serum calcium, vitamin D, and PTH. Student t test, Fisher exact test, or linear regression was used to determine significance.
RESULTS: Calcium, vitamin D, and PTH levels were drawn on 243 patients following GBP. Forty-one patients had long-limb bypass (LL-GBP), Roux >100 cm, and 202 had short-limb bypass (SL-GBP), Roux < or =100 cm. The mean (+/-SD) postoperative follow-up time was significantly longer in the LL-GBP group (5.7 +/- 2.5 years) than the SL-GBP group (3.1 +/- 3.6 years, P < 0.0001). When corrected for albumin levels, mean calcium was 9.3 mg/dL (range, 8.5-10.8 mg/dL), and no difference existed between LL-GBP and SL-GBP patients. For patients with low vitamin D levels (<8.9 ng/mL), 88.9% had elevated PTH (>65 pg/mL) and 58.0% of patients with normal vitamin D levels (> or =8.9 ng/mL) had elevated PTH (P < 0.0001). In individuals with vitamin D levels <30 ng/mL, 55.1% (n = 103) had elevated PTH, and of those with vitamin D levels > or =30 ng/mL 28.5% (n = 16) had elevated PTH (P = 0.0007). Mean vitamin D levels were lower in patients who had undergone LL-GBP as opposed to those with SL-GBP, 16.8 +/- 10.8 ng/mL versus 22.7 +/- 11.1 ng/mL (P = 0.0022), and PTH was significantly higher in patients who had a LL-GBP (113.5 +/- 88.0 pg/mL versus 74.5 +/- 52.7 pg/mL, P = 0.0002). There was a linear decrease in vitamin D (P = 0.005) coupled with a linear increase in PTH (P < 0.0001) the longer patients were followed after GBP. Alkaline phosphatase levels were elevated in 40.3% of patients and correlated with PTH levels.
CONCLUSION: Vitamin D deficiency and elevated PTH are common following GBP and progress over time. There is a significant incidence of secondary hyperparathyroidism in short-limb GBP patients, even those with vitamin D levels > or =30 ng/mL, suggesting selective Ca malabsorption. Thus, calcium malabsorption is inherent to gastric bypass. Careful calcium and vitamin D supplementation and long-term screening are necessary to prevent deficiencies and the sequelae of secondary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16633006      PMCID: PMC1570540          DOI: 10.1097/01.sla.0000216773.47825.c1

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding: a comparative study of 1,200 cases.

Authors:  Laurent Biertho; Rudolf Steffen; Thomas Ricklin; Fritz F Horber; Alfons Pomp; William B Inabnet; Daniel Herron; Michel Gagner
Journal:  J Am Coll Surg       Date:  2003-10       Impact factor: 6.113

Review 2.  Metabolic bone disease after gastric bypass surgery for obesity.

Authors:  Claudio De Prisco; Steven N Levine
Journal:  Am J Med Sci       Date:  2005-02       Impact factor: 2.378

Review 3.  Methods for voluntary weight loss and control. NIH Technology Assessment Conference Panel.

Authors: 
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

Review 4.  Functional indices of vitamin D status and ramifications of vitamin D deficiency.

Authors:  Robert P Heaney
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

5.  Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D.

Authors:  Jason M Johnson; James W Maher; Isaac Samuel; Deborah Heitshusen; Cornelius Doherty; Robert W Downs
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

6.  The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery.

Authors:  Nahid Hamoui; Kiwan Kim; Gary Anthone; Peter F Crookes
Journal:  Arch Surg       Date:  2003-08

7.  Severe metabolic bone disease as a long-term complication of obesity surgery.

Authors:  Whitney S Goldner; Thomas M O'Dorisio; Joseph S Dillon; Edward E Mason
Journal:  Obes Surg       Date:  2002-10       Impact factor: 4.129

8.  Late effects of gastric bypass for obesity.

Authors:  L V Crowley; J Seay; G Mullin
Journal:  Am J Gastroenterol       Date:  1984-11       Impact factor: 10.864

9.  Bone and gastric bypass surgery: effects of dietary calcium and vitamin D.

Authors:  Lisa R Goode; Robert E Brolin; Hasina A Chowdhury; Sue A Shapses
Journal:  Obes Res       Date:  2004-01

10.  Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery.

Authors:  Guy H Slater; Christine J Ren; Niccole Siegel; Trudy Williams; Di Barr; Barrie Wolfe; Kevin Dolan; George A Fielding
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

View more
  57 in total

Review 1.  Managing medical and surgical disorders after divided Roux-en-Y gastric bypass surgery.

Authors:  Bikram Bal; Timothy R Koch; Frederick C Finelli; Michael G Sarr
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-11       Impact factor: 46.802

Review 2.  Effects of weight loss on bone status after bariatric surgery: association between adipokines and bone markers.

Authors:  Hélène Wucher; Cécile Ciangura; Christine Poitou; Sébastien Czernichow
Journal:  Obes Surg       Date:  2007-12-11       Impact factor: 4.129

Review 3.  Bone Health following Bariatric Surgery: Implications for Management Strategies to Attenuate Bone Loss.

Authors:  Tair Ben-Porat; Ram Elazary; Shiri Sherf-Dagan; Ariela Goldenshluger; Ronit Brodie; Yoav Mintz; Ram Weiss
Journal:  Adv Nutr       Date:  2018-03-01       Impact factor: 8.701

Review 4.  Heterotopic mesenteric ossification following gastric bypass surgery: case series and review of literature.

Authors:  Arthur Yushuva; Prachi Nagda; Kei Suzuki; Omar H Llaguna; Dimitrios Avgerinos; Elliot Goodman
Journal:  Obes Surg       Date:  2010-02-02       Impact factor: 4.129

5.  Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats.

Authors:  Kerstin Stemmer; Maximilian Bielohuby; Bernadette E Grayson; Denovan P Begg; Adam P Chambers; Christina Neff; Stephen C Woods; Reinhold G Erben; Matthias H Tschöp; Martin Bidlingmaier; Thomas L Clemens; Randy J Seeley
Journal:  Endocrinology       Date:  2013-04-03       Impact factor: 4.736

6.  Effect of Gastric Bypass on Bone Mineral Density, Parathyroid Hormone and Vitamin D: 5 Years Follow-up.

Authors:  Mustafa Raoof; Ingmar Näslund; Eva Rask; Eva Szabo
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

Review 7.  Bone Health After Bariatric Surgery.

Authors:  Claudia Gagnon; Anne L Schafer
Journal:  JBMR Plus       Date:  2018-05-01

8.  Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass.

Authors:  Juan P Valderas; Soledad Velasco; Sandra Solari; Yessica Liberona; Paola Viviani; Alberto Maiz; Alex Escalona; Gilberto González
Journal:  Obes Surg       Date:  2009-06-11       Impact factor: 4.129

9.  Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status.

Authors:  Anne L Schafer; Connie M Weaver; Dennis M Black; Amber L Wheeler; Hanling Chang; Gina V Szefc; Lygia Stewart; Stanley J Rogers; Jonathan T Carter; Andrew M Posselt; Dolores M Shoback; Deborah E Sellmeyer
Journal:  J Bone Miner Res       Date:  2015-05-21       Impact factor: 6.741

10.  Utilization of preoperative patient factors to predict postoperative vitamin D deficiency for patients undergoing gastric bypass.

Authors:  Judy Jin; Thomas A Stellato; Peter T Hallowell; Margaret Schuster; Kristen Graf; Scott Wilhelm
Journal:  J Gastrointest Surg       Date:  2009-03-13       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.